News

Senegal says hydroxychloroquine virus treatment is promising

April 2, 2020 08:37 PM


Senegal is set to continue administering hydroxychloroquine to coronavirus patients, a senior health official said Thursday, after encouraging results for those treated with the venerable anti-malarial drug.

Both chloroquine and hydroxychloroquine are drugs ordinarily used to treat malaria, but early small-scale studies suggest they reduce virus levels among people badly infected by COVID-19.

Some countries have rushed to use the drugs but many scientists are urging caution until larger trials show whether they are safe and effective.

In a televised statement on Thursday, Moussa Seydi, the doctor in charge of treating Senegalese COVID-19 patients, said there was anecdotal evidence that people treated with hydroxychloroquine recovered faster.

"When it comes to science, observation alone is not enough and extensive research is needed before an opinion can be validated," he added, also urging people to avoid risky self-medication. "But the results we have seen reassure us and reassure my whole team, and we will continue in this direction."

Details about the trial in Senegal are scant. Seydi told AFP last week that about half of Senegal's COVID-19 patients were being treated with hydroxychloroquine. On Thursday, he did not offer any further details about dosage, the exact number under treatment, the age-range of the patients or whether they had any underlying medical conditions.

Senegal has recorded 195 confirmed coronavirus cases to date, of whom one has died. Chloroquine and hydroxychloroquine have been used for decades against malaria and are considered cheap and safe when used correctly. However, they also have potentially serious side effects, especially when taken in high doses or administered in tandem with other medications.

Seydi said that patients under his care had exhibited "no side effects," and that he and his team will trial combining hydroxychloroquine with the antibiotic azithromycin in the aim of achieving better results. 

The European Medicine Agency warned on Wednesday that neither chloroquine nor hydroxychloroquine should be used to treat COVID-19 cases, except for clinical trials or in the event of a "national emergency."

 

https://www.youtube.com/watch?v=pOavNaBX4NU


Most Read

  1. Yet another burden on people: Govt hikes oil prices Yet another burden on people: Govt hikes oil prices
  2. Foreigners safe after suicide-bomber targets their van in Karachi Foreigners safe after suicide-bomber targets their van in Karachi
  3. Public reacts to Bohemia's music video ‘Salsa’ starring Sistrology Public reacts to Bohemia's music video ‘Salsa’ starring Sistrology
  4. Saudis offered PIA, airports, joint ventures to build five-star hotels Saudis offered PIA, airports, joint ventures to build five-star hotels
  5. Finance minister rules out further rupee devaluation Finance minister rules out further rupee devaluation
  6. Mehar Bano and Mamya Shajaffar’s bold dance videos invite public's wrath Mehar Bano and Mamya Shajaffar’s bold dance videos invite public's wrath

Opinion

  1. Insights into the Pakistan Stock Exchange's Recent Record High Triumph
    Insights into the Pakistan Stock Exchange's Recent Record High Triumph

    By Zulfiqar Ali Mir

  2. IMEC to sabotage CPEC
    IMEC to sabotage CPEC

    By Dr Asif Channer

  3. 1947 TO FORM 47
    1947 TO FORM 47

    By Dr Asif Channer

  4. Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....
    Beijing wants to further highlight industrial sector in its country and take scientific innovation to new heights....

    By Ali Ramay

  5. Global race: China will reduce its unnecessary expenses
    Global race: China will reduce its unnecessary expenses

    By Ali Ramay

  6. Channer Pir: The Great Saint of Cholistan
    Channer Pir: The Great Saint of Cholistan

    By Dr Asif Channer